SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-21-066320
Filing Date
2021-12-20
Accepted
2021-12-20 16:06:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea152600-f1_nlspharma.htm F-1 280941
2 OPINION OF WENGER & VIELI AG, SWISS COUNSEL TO NLS PHARMACEUTICS LTD ea152600ex5-1_nlspharma.htm EX-5.1 25879
3 CONSENT OF PRICEWATERHOUSECOOPERS AG ea152600ex23-1_nlspharma.htm EX-23.1 3118
4 GRAPHIC image_001.jpg GRAPHIC 14050
5 GRAPHIC ex5-1_001.jpg GRAPHIC 3283
6 GRAPHIC ex23-1_001.jpg GRAPHIC 34979
  Complete submission text file 0001213900-21-066320.txt   383324
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-261766 | Film No.: 211505294
SIC: 2834 Pharmaceutical Preparations